An API firm with a history of J&J funding scores a major loan to advance its portfolio

A Massachusetts-based company that manufactures APIs closed its Series A and B fundraising, with J&J among the list of investors. Now, the company is announcing another $49 million loan to help boost operations.Entrinsic Bioscience — or EBS — expects to use the loan to fund programs for GI, airway and skin diseases. CEO Stephen Gatto called these programs a “blueprint for serial innovation” in a press release.

The company boasts that it was the first to discover patented combinations of small-molecule amino acids that can modulate targeted epithelial transmembrane proteins through cell signaling. Its first commercialized product is enterade advanced oncology formula, a sugar-free medical food that can help manage side effects from chemotherapy, such as nausea, diarrhea and weight maintenance.

endpts.com

logo

Logistic 3PL
Center Biokon

We are in social networks

9.00 to 18.00
+38 (044) 585-11-80
+38 (044) 585-11-81
trade@biocon-bc.com
9 Boryspilska St., Velyka Olexandrovka Village, Boryspilskyi District, 08320, Kyiv Region

© 2021 «BIOKON» All rights reserved.